Cost-effectiveness of pancreatic cancer screening: Time for a more tailored approach.
作者信息
Archibugi Livia, Capurso Gabriele, Canto Marcia Irene
机构信息
Pancreato-Biliary Endoscopy and Endosonography Division, Pancreas Translational & Clinical Research Center, San Raffaele Scientific Institute IRCCS, Vita-Salute San Raffaele University, Milan, Italy.
Division of Gastroenterology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
出版信息
United European Gastroenterol J. 2023 Apr;11(3):264-266. doi: 10.1002/ueg2.12380. Epub 2023 Mar 20.
Abstract
摘要
相似文献
1
Cost-effectiveness of pancreatic cancer screening: Time for a more tailored approach.胰腺癌筛查的成本效益：是时候采用更具针对性的方法了。
United European Gastroenterol J. 2023 Apr;11(3):264-266. doi: 10.1002/ueg2.12380. Epub 2023 Mar 20.
2
Cost-effectiveness of Abdominal Ultrasound Versus Magnetic Resonance Imaging for Pancreatic Cancer Screening in Familial High-Risk Individuals in Japan.日本家族性高危人群胰腺癌筛查中腹部超声与磁共振成像的成本效益比较。
Pancreas. 2020 Sep;49(8):1052-1056. doi: 10.1097/MPA.0000000000001614.
3
Cost-effectiveness of Pancreatic Cancer Surveillance in High-Risk Individuals: An Economic Analysis.高危个体胰腺癌监测的成本效益：一项经济学分析。
Pancreas. 2019 Apr;48(4):526-536. doi: 10.1097/MPA.0000000000001268.
4
Screening patients at high risk for pancreatic cancer-Is it time for a paradigm shift?筛查胰腺癌高危患者——是否到了范式转变的时候？
J Surg Oncol. 2019 Oct;120(5):851-857. doi: 10.1002/jso.25616. Epub 2019 Jul 16.
5
Role of endoscopic ultrasound in the screening and follow-up of high-risk individuals for familial pancreatic cancer.内镜超声在家族性胰腺癌高危人群筛查和随访中的作用。
World J Gastroenterol. 2019 Sep 14;25(34):5082-5096. doi: 10.3748/wjg.v25.i34.5082.
6
AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review.美国胃肠病学会关于高危个体胰腺癌筛查的临床实践更新：专家综述
Gastroenterology. 2020 Jul;159(1):358-362. doi: 10.1053/j.gastro.2020.03.088. Epub 2020 May 19.
7
Pancreatic Cancer Surveillance and Novel Strategies for Screening.胰腺癌监测与新型筛查策略。
Gastrointest Endosc Clin N Am. 2022 Jan;32(1):13-25. doi: 10.1016/j.giec.2021.08.008.
8
Screening for pancreatic cancer in familial high-risk individuals: A systematic review.对家族性高危个体进行胰腺癌筛查：一项系统评价。
World J Gastroenterol. 2015 Jul 28;21(28):8678-86. doi: 10.3748/wjg.v21.i28.8678.
9
New strategies for the early detection of pancreatic cancer.胰腺癌早期检测的新策略。
Expert Rev Gastroenterol Hepatol. 2016;10(2):157-9. doi: 10.1586/17474124.2016.1122521. Epub 2015 Dec 14.
10
Challenges and Opportunities in Pancreatic Cancer Screening Among High-Risk Individuals.高危个体胰腺癌筛查中的挑战与机遇
Gastroenterology. 2022 Jun;162(7):2113-2120. doi: 10.1053/j.gastro.2022.03.040. Epub 2022 Mar 29.
本文引用的文献
1
Cost-effectiveness of pancreas surveillance: The CDKN2A-p16-Leiden cohort.胰腺监测的成本效益：CDKN2A-p16-Leiden 队列研究。
United European Gastroenterol J. 2023 Mar;11(2):163-170. doi: 10.1002/ueg2.12360. Epub 2023 Feb 13.
2
Cancer statistics, 2023.癌症统计数据，2023 年。
CA Cancer J Clin. 2023 Jan;73(1):17-48. doi: 10.3322/caac.21763.
3
The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and Survival.多中心胰腺癌筛查研究：对分期和生存的影响。
J Clin Oncol. 2022 Oct 1;40(28):3257-3266. doi: 10.1200/JCO.22.00298. Epub 2022 Jun 15.
4
Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk Factors.风险调整后的癌症筛查与预防（RiskAP）：通过基于风险因素的学习型筛查补充早期疾病检测筛查
Breast Care (Basel). 2022 Apr;17(2):208-223. doi: 10.1159/000517182. Epub 2021 Aug 12.
5
Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant: Yield and Outcomes of a 20-Year Prospective Follow-Up.携带种系致病变异者的胰腺癌监测：20年前瞻性随访的结果与转归
J Clin Oncol. 2022 Oct 1;40(28):3267-3277. doi: 10.1200/JCO.22.00194. Epub 2022 Jun 3.
6
Protein biomarkers in pancreatic juice and serum for identification of pancreatic cancer.胰液和血清中的蛋白质生物标志物用于胰腺癌的鉴定。
Gastrointest Endosc. 2022 Nov;96(5):801-813.e2. doi: 10.1016/j.gie.2022.04.1342. Epub 2022 May 7.
7
Hereditary pancreatic cancer.遗传性胰腺癌。
Int J Clin Oncol. 2021 Oct;26(10):1784-1792. doi: 10.1007/s10147-021-02015-6. Epub 2021 Sep 2.
8
UEG position paper on pancreatic cancer. Bringing pancreatic cancer to the 21st century: Prevent, detect, and treat the disease earlier and better.欧洲胃肠病学会关于胰腺癌的立场文件。将胰腺癌带入 21 世纪：更早、更好地预防、检测和治疗疾病。
United European Gastroenterol J. 2021 Sep;9(7):860-871. doi: 10.1002/ueg2.12123. Epub 2021 Aug 25.
9
Threshold Analysis of the Cost-effectiveness of Endoscopic Ultrasound in Patients at High Risk for Pancreatic Ductal Adenocarcinoma.内镜超声检查在高风险胰腺导管腺癌患者成本效益的阈值分析。
Pancreas. 2021 Jul 1;50(6):807-814. doi: 10.1097/MPA.0000000000001835.
10
Long-term yield of pancreatic cancer surveillance in high-risk individuals.高危人群的胰腺癌监测的长期获益。
Gut. 2022 Jun;71(6):1152-1160. doi: 10.1136/gutjnl-2020-323611. Epub 2021 Apr 5.
Zotero 插件